FilingSEC EDGAR8-K
HCW Biologics Withdraws Equity Plan Proposal
· SEC accepted
StageShareholder Meeting
Filing content
The company withdrew a proposal for a performance-based equity plan following stockholder feedback and rescheduled its special meeting.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…